Fosinopril decreases levels of soluble vascular cell adhesion molecule-1 in Type II diabetic patients suffering from microalbuminuria.
Gasic
S
S
Wagner
O F
OF
Fasching
P
P
Ludwig
C
C
Veitl
M
M
Kapiotis
S
S
Jilma
B
B
D000419:Albuminuria / Q000097:blood*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000188:drug therapy; D005260:Female; D017328:Fosinopril / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D019010:Vascular Cell Adhesion Molecule-1 / Q000097:blood*
D000806:Angiotensin-Converting Enzyme Inhibitors; D019010:Vascular Cell Adhesion Molecule-1; D017328:Fosinopril